SCHEMBL4156

SCHEMBL4156

CN(C)CCC(O)c1cccs1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.48
RAB9A P51151 1/20 0.48
KMT2A Q03164 1/20 0.48
CACNA2D1 P54289 1/20 0.45
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43
SLC6A2 P23975 1/20 0.43
SLC6A4 P31645 1/20 0.43
SLC6A3 Q01959 1/20 0.43
KCNH2 Q12809 1/20 0.43
HTR1A P08908 2/20 0.42
HTR2A P28223 1/20 0.40
HRH1 P35367 1/20 0.40
ALOX5 P09917 1/20 0.39
CES2 O00748 1/20 0.39
CES1 P23141 1/20 0.39
KEAP1 Q14145 1/20 0.39
LMNA P02545 1/20 0.38
TP53 P04637 1/20 0.38
POLB P06746 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL522925 1.00 NPC1 (0.48) NPC1RAB9AKMT2ACACNA2D1CYP3A4
SCHEMBL1200623 1.00 NPC1 (0.48) NPC1RAB9AKMT2ACACNA2D1CYP3A4
SCHEMBL4621336 0.98 NPC1 (0.47) NPC1RAB9AKMT2ACACNA2D1CYP3A4
Hydrochloric Acid SCHEMBL27710967 0.98 NPC1 (0.47) NPC1RAB9AKMT2ACACNA2D1CYP3A4
SCHEMBL4619913 0.98 NPC1 (0.47) NPC1RAB9AKMT2ACACNA2D1CYP3A4
Hydrochloric Acid SCHEMBL27899374 0.98 NPC1 (0.47) NPC1RAB9AKMT2ACACNA2D1CYP3A4
SCHEMBL4621986 0.98 NPC1 (0.47) NPC1RAB9AKMT2ACACNA2D1CYP3A4
Alcohol SCHEMBL6236373 0.95 CACNA2D1 (0.48) NPC1RAB9AKMT2ACACNA2D1CYP3A4
Tetrahydrothiophene SCHEMBL12971275 0.89 NPC1 (0.41) NPC1RAB9AKMT2ACACNA2D1CYP3A4
SCHEMBL28016938 0.89 CACNA2D1 (0.42) NPC1RAB9AKMT2ACACNA2D1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 462 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119912460-A Porphyrin derivatives, process for their preparation and their use for bacteriostasis 上海光声制药有限公司 2025-05-02 CN claimed
CN-114163415-B Preparation method of duloxetine hydrochloride intermediate 珠海润都制药股份有限公司 2023-03-03 CN claimed
CN-115286613-B Preparation method of duloxetine hydrochloride 潍坊市海欣药业有限公司 2023-01-31 CN claimed
CN-115286613-A Preparation method of duloxetine hydrochloride 潍坊市海欣药业有限公司 2022-11-04 CN claimed
CN-114437022-A Preparation method of duloxetine intermediate 浙江拓普药业股份有限公司 2022-05-06 CN claimed
CN-114163415-A Preparation method of duloxetine hydrochloride intermediate 珠海润都制药股份有限公司 2022-03-11 CN claimed
CN-109769856-B Diatomite insecticide, preparation method and application thereof 广州弘源优农科技有限公司 2021-09-10 CN claimed
CN-112126663-A Production process of duloxetine 浙江拓普药业股份有限公司 2020-12-25 CN claimed
CN-106011096-B Engineered ketoreductase polypeptide and method for preparing (S) -3- (dimethylamino) -1- (thiophene-2-yl) -1-propanol by using same 苏州汉酶生物技术有限公司 2020-11-03 CN claimed
CN-109769856-A Diatomaceous earth, preparation method and application 广州弘源优农科技有限公司 2019-05-21 CN claimed
WO-2007045405-A1 PROCESS FOR THE PREPARATION OF DULOXETINE SOLMAG S.P.A. (IT) 2007-04-26 WO claimed
CN-1304360-C Preparation method of N,N-dimethyl-3-hydroxy-3-aryl propyl amine UNIV TIANJIN (CN) 2007-03-14 CN claimed
CN-1896071-A Preparation of (S-(+)-N,N-methyl-3-(1-naphthyl-oxy)-3-(2-thienyl) propylamine AILISI MEDICAL SCIENCE AND TEC (CN) 2007-01-17 CN claimed
WO-2006126213-A1 AN IMPROVED PROCESS FOR THE PREPARATION OF DULOXETINE MATRIX LABORATORIES LTD (IN) 2006-11-30 WO claimed
CN-1497048-A Method for preparing 3-heteroarylradical-3-hydroxy-propionic acid derivative 拜尔公司 2004-05-19 CN claimed
US-6541668-B1 Using nucleophilic aromatic displacement in 1,3-dimethyl-2-imidazolidinone or N-methylpyrrolidinone ELI LILLY AND COMPANY 2003-04-01 US claimed
EP-0650965-B1 Asymmetric synthesis of (S)-(+)-N,N-dimethyl-3-(1-naphthalenyloxy)-3-(2-thienyl)propanamine an intermediate in the preparation of duloxetine LILLY CO ELI (US) 2001-02-07 EP claimed
EP-0650965-A1 Asymmetric synthesis of (S)-(+)-N,N-dimethyl-3-(1-naphthalenyloxy)-3-(2-thienyl)propanamine an intermediate in the preparation of duloxetine ELI LILLY AND COMPANY (US) 1995-05-03 EP claimed
US-5362886-A Asymmetric synthesis ELI LILLY AND COMPANY (US) 1994-11-08 US claimed
EP-0457559-A2 Chiral synthesis of 1-aryl-3-aminopropan-1-ols ELI LILLY AND COMPANY (US) 1991-11-21 EP claimed